BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36921289)

  • 1. Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
    Peigné M; Simon V; Pigny P; Mimouni NEH; Martin C; Dewailly D; Catteau-Jonard S; Giacobini P
    Hum Reprod; 2023 May; 38(5):938-950. PubMed ID: 36921289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the distribution of serum anti-müllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study.
    Tzeng CR; Huang Z; Asada Y; Zhang C; Ho MT; Li RHW; Kim JH; Govindarajan M; Vuyavanich T; Sini I; Wong PS; Singh S; Lin WY; Ho NT
    Hum Reprod; 2023 Jul; 38(7):1368-1378. PubMed ID: 37105234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB; Vanky E; Carlsen SM
    Hum Reprod; 2012 Aug; 27(8):2494-502. PubMed ID: 22693172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.
    Abbott DH; Rayome BH; Dumesic DA; Lewis KC; Edwards AK; Wallen K; Wilson ME; Appt SE; Levine JE
    Hum Reprod; 2017 Apr; 32(4):923-936. PubMed ID: 28333238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11β-hydroxyandrostenedione concentrations.
    Wang Z; Van Faassen M; Groen H; Cantineau AEP; Van Oers A; Van der Veen A; Hawley JM; Keevil BG; Kema IP; Hoek A
    Hum Reprod; 2024 May; 39(5):1078-1088. PubMed ID: 38503490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
    Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
    Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of anti-Müllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome.
    Jiang L; Ruan X; Li Y; Gu M; Cheng J; Wang Y; Yang Y; Xu C; Wang Z; Liu L; Mueck AO
    Gynecol Endocrinol; 2023 Dec; 39(1):2206927. PubMed ID: 37141919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
    Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
    Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.